Table 3 Combination index data for Non-Constant combo (artesunate + ruxolitinib).

From: Combination of artesunate and ruxolitinib suppresses T cell leukemia/lymphoma proliferation via the JAK STAT pathway

Dose ART(µM)

Dose RUX(µM)

Effect

CI

7.5

10

0.6171

1.18654

7.5

20

0.5518

1.07903

7.5

40

0.4179

0.79481

15

10

0.5138

0,96857

15

20

0.4681

0.91652

15

40

0.3999

0.87563

20

30

0.39702

0.82647

  1. ART, artesunate; CI, combination index; RUX, ruxolitinib.
Back to article page